
Share on:
MRPC, a single-source provider of medical device components and assemblies, has created significant quality improvements for two clients that brought production of their molded components back to the U.S. from offshore manufacturers.
While these clients initially transitioned their manufacturing productions to offshore molders to drive cost savings, they quickly realized that these savings were achieved at the expense of component quality, may be negligible when the expense of international shipping is factored in and may present challenges for highly regulated industries, where material quality and certifications must be factored into the production process. (Source: MRPC)
RELATED ARTICLES
Sandvik to Divest Additive Manufacturing Business Unit
Jun 16 2026 , Julie A. Vetalice
Cretex Medical Acquires Select Assets and Capabilities of Holland Molds
Jun 16 2026 , Julie A. Vetalice
Medical Component Specialists Appoints President & CEO
Jun 15 2026 , Julie A. Vetalice



